Hossein Esmaeili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hossein Esmaeili has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Seyed Mehdi Joghataei
University of Tehran
12 shared publicationsMona Hamedi
Department of Veterinary Pathobiology Sciences, Faculty of Veterinary Medicine, Islamic Azad University, Science and Research Branch, Tehran, Iran
5 shared publicationsDelia Lacasta
Departamento de Patología Animal, Facultad de Veterinaria de Zaragoza, Universidad de Zaragoza, Zaragoza, Spain
4 shared publicationsAmir Pasha Shakeri
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publicationsMohammadreza Ghorani
Department of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran
3 shared publications- Sergio Villanueva-Saz
Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain
3 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Springer Nature in BMC Veterinary Research
Phylogenetic typing of Escherichia coli isolated from goat kids with Hemorrhagic Abomasitis and associated clinical findings
- 22 October 2026
- Published by Springer Nature in BMC Veterinary Research
Open AccessPhylogenetic typing of Escherichia coli isolated from goat kids with Hemorrhagic Abomasitis and associated clinical findings
- 16 February 2026
- Published by Springer Nature
- p. 29-39
Abortion in Goats: Differential Diagnosis
- 16 February 2026
- Published by Springer Nature
- p. 1198-1209
Sheep and Goat Pox
- Open Access
- 28 January 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Clinical characterization and genotypic identification of border disease virus in sheep breeds in Iran
Border disease (BD), caused by Border Disease Virus (BDV), leads to reproductive losses, congenital defects, and persistently infected (PI) lambs that main
- 28 January 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Open AccessClinical characterization and genotypic identification of border disease virus in sheep breeds in Iran
Border disease (BD), caused by Border Disease Virus (BDV), leads to reproductive losses, congenital defects, and persistently infected (PI) lambs that main
- Open Access
- 1 January 2026
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 20 (1) , 53-66
Outbreak of Bluetongue Disease in Zel Sheep Flocks in Mazandaran Province, Iran
Background: Bluetongue (BT) is a significant arthropod-borne viral disease affecting sheep, with varying clinical manifestations depending on the strain of the virus, the host breed, their immune status, and environmental conditions. While endemic in Iran, few studies have focused on outbreaks, particularly in native breeds. Objectives: This study aims to provide comprehensive data on the clinical presentation, post-mortem findings, and molecular diagnosis of a BT outbreak in Zel sheep flocks in Mazandaran Province, Iran, to better understand the virus’s impact and precognition. Methods: During the 2018 outbreak, clinical and post-mortem evaluations were conducted on 12 flocks (1800 sheep). Samples, including blood and tissue from both live and dead sheep, were collected and analyzed using reverse transcription polymerase chain reaction (RT-PCR) and nested PCR to confirm BT virus (BTV) presence. Results: Clinical, necropsy observations, and molecular analysis confirmed BTV infection in both live and dead sheep. The morbidity rate was approximately 13.33%, with a mortality rate of 2.11% across the entire population and 15.83% among the infected sheep. The most common clinical signs observed were high fever (80%), swelling and edema of the lips and face (96.25%), and redness of the buccal and nasal mucosa (87.5%). Nasal discharge and frothy, blood-stained salivation were present in 15% of the infected sheep, while tongue erosion and ulcers affected 22.9%. Necropsies revealed 100% mucosal lesions, hemorrhagic pulmonary artery lesions in 81.6%, and systemic congestion of major organs in 50% of cases. Serous effusions were found in 42%, indicating severe systemic involvement in the dead sheep. These findings align with reports from other regions experiencing BTV outbreaks and suggest that climatic conditions and vector proliferation contributed to the spread of the disease. Conclusion: This study reaffirms the enzootic nature of BT in Iran and stresses the critical role of clinical, necropsy, and molecular diagnostics in managing BT outbreaks. To minimize future outbreaks and economic losses from BTV’s effects on sheep health in the regions, adopting preventive measures such as vaccination programs, serotype monitoring, enhanced surveillance, vector control, and regulation of livestock movement is recommended.
- 1 January 2026
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 20 (1) , 53-66
Open AccessOutbreak of Bluetongue Disease in Zel Sheep Flocks in Mazandaran Province, Iran
Background: Bluetongue (BT) is a significant arthropod-borne viral disease affecting sheep, with varying clinical manifestations depending on the strain of the virus, the host breed, their immune status, and environmental conditions. While endemic in Iran, few studies have focused on outbreaks, particularly in native breeds. Objectives: This study aims to provide comprehensive data on the clinical presentation, post-mortem findings, and molecular diagnosis of a BT outbreak in Zel sheep flocks in Mazandaran Province, Iran, to better understand the virus’s impact and precognition. Methods: During the 2018 outbreak, clinical and post-mortem evaluations were conducted on 12 flocks (1800 sheep). Samples, including blood and tissue from both live and dead sheep, were collected and analyzed using reverse transcription polymerase chain reaction (RT-PCR) and nested PCR to confirm BT virus (BTV) presence. Results: Clinical, necropsy observations, and molecular analysis confirmed BTV infection in both live and dead sheep. The morbidity rate was approximately 13.33%, with a mortality rate of 2.11% across the entire population and 15.83% among the infected sheep. The most common clinical signs observed were high fever (80%), swelling and edema of the lips and face (96.25%), and redness of the buccal and nasal mucosa (87.5%). Nasal discharge and frothy, blood-stained salivation were present in 15% of the infected sheep, while tongue erosion and ulcers affected 22.9%. Necropsies revealed 100% mucosal lesions, hemorrhagic pulmonary artery lesions in 81.6%, and systemic congestion of major organs in 50% of cases. Serous effusions were found in 42%, indicating severe systemic involvement in the dead sheep. These findings align with reports from other regions experiencing BTV outbreaks and suggest that climatic conditions and vector proliferation contributed to the spread of the disease. Conclusion: This study reaffirms the enzootic nature of BT in Iran and stresses the critical role of clinical, necropsy, and molecular diagnostics in managing BT outbreaks. To minimize future outbreaks and economic losses from BTV’s effects on sheep health in the regions, adopting preventive measures such as vaccination programs, serotype monitoring, enhanced surveillance, vector control, and regulation of livestock movement is recommended.
- 8 December 2025
- Published by Elsevier in The Veterinary Journal
- Vol. 315, 106533
Congenital anomalies in sheep and goats in Iran over ten years
- 8 December 2025
- Published by Elsevier in The Veterinary Journal
- Vol. 315, 106533
Congenital anomalies in sheep and goats in Iran over ten years
- 26 July 2025
- Published by Springer Nature
- p. 1-11
Abortion in Goats: Differential Diagnosis
- 24 June 2025
- Published by Springer Nature
- p. 1-11
Sheep and Goat Pox
- Open Access
- 8 May 2025
- Published by Springer Nature in BMC Veterinary Research
- Vol. 21 (1) , 1-12
Optimal immunization strategies for Saanen goats against goatpox
Goatpox is a highly contagious disease caused by the Capripoxvirus, primarily affecting sheep and goats. Breeds like the Saanen are particularly vulnerable, especially in enzootic areas, and face risks not only from the disease itself but also from adverse reactions to live attenuated vaccines. This study compares inactivated and attenuated vaccines to find the safest and most effective vaccination strategy for Saanen goats against the Goatpox Virus (GTPV). In this study, 375 pure-breed Saanen goats were strategically divided into four groups to explore the most effective vaccination protocols for combating combinations of vaccines. In contrast, one group remained unvaccinated as a control. After vaccination, the goats were challenged by exposure to naturally infected animals to assess the vaccines’ protective efficacy. PCR assays and the Virus Neutralization method were also conducted. Group G1 exhibited no adverse reactions following two inactivated vaccines, with only mild and brief signs observed in a small number of goats (2%) after the live attenuated vaccine. Group G2, which received an inactivated vaccine followed by a live attenuated vaccine, had mild lesions in 18.66% of the goats after vaccination. In contrast, Group G3, which only received the live attenuated vaccine, showed a high morbidity rate of 82% and a mortality rate of 22%, with severe clinical signs and Pox lesions. Following the challenge, no signs of GTPV infection were observed in Groups G1, G2, and G3, whereas the control group exhibited 100% morbidity and 72% mortality, confirming the vaccine’s protective efficacy. This study found that a protocol using two inactivated vaccine doses at one-month intervals, followed by a live attenuated vaccine and annual boosters, effectively immunizes vulnerable breeds against GTPV without causing adverse reactions. This approach prevents complications and supports breeding in GTPV-enzootic regions.
- 8 May 2025
- Published by Springer Nature in BMC Veterinary Research
- Vol. 21 (1) , 1-12
Open AccessOptimal immunization strategies for Saanen goats against goatpox
Goatpox is a highly contagious disease caused by the Capripoxvirus, primarily affecting sheep and goats. Breeds like the Saanen are particularly vulnerable, especially in enzootic areas, and face risks not only from the disease itself but also from adverse reactions to live attenuated vaccines. This study compares inactivated and attenuated vaccines to find the safest and most effective vaccination strategy for Saanen goats against the Goatpox Virus (GTPV). In this study, 375 pure-breed Saanen goats were strategically divided into four groups to explore the most effective vaccination protocols for combating combinations of vaccines. In contrast, one group remained unvaccinated as a control. After vaccination, the goats were challenged by exposure to naturally infected animals to assess the vaccines’ protective efficacy. PCR assays and the Virus Neutralization method were also conducted. Group G1 exhibited no adverse reactions following two inactivated vaccines, with only mild and brief signs observed in a small number of goats (2%) after the live attenuated vaccine. Group G2, which received an inactivated vaccine followed by a live attenuated vaccine, had mild lesions in 18.66% of the goats after vaccination. In contrast, Group G3, which only received the live attenuated vaccine, showed a high morbidity rate of 82% and a mortality rate of 22%, with severe clinical signs and Pox lesions. Following the challenge, no signs of GTPV infection were observed in Groups G1, G2, and G3, whereas the control group exhibited 100% morbidity and 72% mortality, confirming the vaccine’s protective efficacy. This study found that a protocol using two inactivated vaccine doses at one-month intervals, followed by a live attenuated vaccine and annual boosters, effectively immunizes vulnerable breeds against GTPV without causing adverse reactions. This approach prevents complications and supports breeding in GTPV-enzootic regions.
- Open Access
- 1 April 2025
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 19 (02) , 227-236
Clinical Presentation and Diagnosis of Anthrax in Iranian Goats
Background: Anthrax is considered one of the most important zoonotic diseases due to its widespread distribution, significant economic losses, and potential risks to public health. The manifestation of anthrax in goats is comparable to its presentation in other small ruminants. Objectives: To enhance understanding of the clinical signs and post-mortem findings of anthrax and improve its diagnosis in the goat population of Iran, this study examined the occurrence of anthrax in goats in some provinces of Iran between 2016 and 2021. Methods: Among a population of 3,465 goats, 50 cases of sudden death were documented. Samples were collected from recently deceased animals, including bone marrow and blood from ear veins. These samples were sent to the laboratory for direct examination, culture, and molecular assay (polymerase chain reaction [PCR]). Results: Out of the collected samples, 36 cases were attributed to anthrax. Among these deaths, 27 animals were found dead, while nine goats were slaughtered before succumbing. Bacillus anthracis was confirmed in all 36 suspicious samples using direct examination and PCR. Additionally, 11 samples (30%) were found to be culture-positive for anthrax. It is worth noting that classic signs of anthrax, such as unclotted blood oozing from natural orifices and the absence of rigor mortis, were not observed in 19 dead goats. Conclusion: This study reveals that there are instances of anthrax in goats where the typical clinical signs, such as blood oozing from natural body orifices, are absent. This finding should be considered during the differential diagnosis, especially when the classic signs are used as criteria.
- 1 April 2025
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 19 (02) , 227-236
Open AccessClinical Presentation and Diagnosis of Anthrax in Iranian Goats
Background: Anthrax is considered one of the most important zoonotic diseases due to its widespread distribution, significant economic losses, and potential risks to public health. The manifestation of anthrax in goats is comparable to its presentation in other small ruminants. Objectives: To enhance understanding of the clinical signs and post-mortem findings of anthrax and improve its diagnosis in the goat population of Iran, this study examined the occurrence of anthrax in goats in some provinces of Iran between 2016 and 2021. Methods: Among a population of 3,465 goats, 50 cases of sudden death were documented. Samples were collected from recently deceased animals, including bone marrow and blood from ear veins. These samples were sent to the laboratory for direct examination, culture, and molecular assay (polymerase chain reaction [PCR]). Results: Out of the collected samples, 36 cases were attributed to anthrax. Among these deaths, 27 animals were found dead, while nine goats were slaughtered before succumbing. Bacillus anthracis was confirmed in all 36 suspicious samples using direct examination and PCR. Additionally, 11 samples (30%) were found to be culture-positive for anthrax. It is worth noting that classic signs of anthrax, such as unclotted blood oozing from natural orifices and the absence of rigor mortis, were not observed in 19 dead goats. Conclusion: This study reveals that there are instances of anthrax in goats where the typical clinical signs, such as blood oozing from natural body orifices, are absent. This finding should be considered during the differential diagnosis, especially when the classic signs are used as criteria.